Chen, Min-Shan
Sun Yat-Sen University
H-index: 64
Asia-China
Top articles of Chen, Min-Shan
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
IMbrave050: Phase 3 study of adjuvant atezolizumab+ bevacizumab versus active surveillance in patients with hepatocellular carcinoma (HCC) at high risk of disease recurrence … | American Association for Cancer Research (AACR) Annual Conference | Pierce Chow Minshan Chen Ann-Lii Cheng Ahmed Kaseb Masatoshi Kudo | 2023/4/14 |
Guidelines for the diagnosis and treatment of primary liver cancer (2022 edition) | Liver Cancer | Jian Zhou Huichuan Sun Zheng Wang Wenming Cong Mengsu Zeng | 2023/10/5 |
Kappa switching DC-DC converter with continuous input and output currents | 2023/6/6 | ||
Efficacy of radiofrequency ablation following transarterial chemoembolisation combined with sorafenib for intermediate stage recurrent hepatocellular carcinoma: a retrospective … | EClinicalMedicine | Xiao-Hui Wang Wen-Bin Duan Wei Liang Hui Li Xiao-Yan Xie | 2023/2/1 |
Efficacy, safety and patient reported outcomes (PROs) from the phase III IMbrave050 trial of adjuvant atezolizumab (atezo)+ bevacizumab (bev) vs active surveillance in patients … | Masatoshi Kudo Minshan Chen Pierce KH Chow Ahmed Omar Kaseb Han Chu Lee | 2023/6/1 | |
Abstract CT003: IMbrave050: Phase 3 study of adjuvant atezolizumab+ bevacizumab versus active surveillance in patients with hepatocellular carcinoma (HCC) at high risk of … | Cancer Research | Pierce Chow Minshan Chen Ann-Lii Cheng Ahmed O Kaseb Masatoshi Kudo | 2023/5/29 |
TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study | International Journal of Surgery | Yichuan Yuan Wei He Zhiwen Yang Jiliang Qiu Zhenkun Huang | 2023/5/1 |
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label … | The Lancet | Shukui Qin Minshan Chen Ann-Lii Cheng Ahmed O Kaseb Masatoshi Kudo | 2023/11/18 |
Systemic therapy for hepatocellular carcinoma: Chinese consensus-based interdisciplinary expert statements | Yongkun Sun Wen Zhang Xinyu Bi Zhengqiang Yang Yu Tang | 2022/1/4 | |
Transarterial infusion chemotherapy with FOLFOX could be an effective and safe treatment for unresectable intrahepatic cholangiocarcinoma | Journal of Oncology | Shaohua Li Min Deng Qiaoxuan Wang Jie Mei Jingwen Zou | 2022/3/15 |
Guidelines for diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus in China (2021 edition) | Liver Cancer | Juxian Sun Rongping Guo Xinyu Bi Mengchao Wu Zhaoyou Tang | 2022/7/5 |
Hepatic arterial infusion chemotherapy as a timing strategy for conversion surgery to treat hepatocellular carcinoma: a single-center real-world study | Journal of hepatocellular carcinoma | Jiongliang Wang Zhikai Zheng Tianqing Wu Wenxuan Li Juncheng Wang | 2022/1/1 |
ASO Visual Abstract: Comparison between Portal Vein Perfusion Chemotherapy and Neoadjuvant Hepatic Arterial Infusion Chemotherapy for Resectable Intermediate/Advanced-Stage … | Annals of Surgical Oncology | Pan Yangxun Mei Jie Jinbin Chen Zhang Deyao Juncheng Wang | 2022/3/1 |
Adjuvant sorafenib following radiofrequency ablation for early-stage recurrent hepatocellular carcinoma with microvascular invasion at the initial hepatectomy | Frontiers in Oncology | Meng-Chao Wei Yao-Jun Zhang Min-Shan Chen Yong Chen Wan-Yee Lau | 2022/6/23 |
Research progress of vascular interventional therapy in the conversion therapy of hepato-cellular carcinoma | CHEN Minshan PAN Yangxun | 2022 | |
Comparison between portal vein perfusion chemotherapy and neoadjuvant hepatic arterial infusion chemotherapy for resectable intermediate to advanced stage hepatocellular carcinoma | Annals of Surgical Oncology | Yangxun Pan Jie Mei Jinbin Chen Deyao Zhang Juncheng Wang | 2022/3/1 |
Antiviral treatments eliminate the adverse impacts of high baseline HBV loads on the survival of HBV-related HCC patients | Journal of Hepatocellular Carcinoma | Zili Hu Xuqi Sun Jie Mei Zhiwen Hu Ziliang Yang | 2022/4/19 |
The role of neoadjuvant conventional transarterial chemoembolization with radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma after initial … | International Journal of Hyperthermia | Zhenwei Peng Xiaoxue Wu Jiaping Li Hui Pang Yaojun Zhang | 2022/12/31 |
Development and validation of a prognostic score for hepatocellular carcinoma patients in immune checkpoint inhibitors therapies: the hepatocellular carcinoma modified Gustave … | Frontiers in Pharmacology | Yongjiang Li Yangxun Pan Ximeng Lin Jingyu Hou Zili Hu | 2022/2/8 |
Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition) | Hui-Chuan Sun Jian Zhou Zheng Wang Xiufeng Liu Qing Xie | 2022/4 |
Co-Authors
